Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000902664-25-003977·PLIANT THERAPEUTICS, INC.
Schedule 13G ownership disclosure
PLIANT THERAPEUTICS INC
Common Stock, par value $0.0001 per share · CUSIP: 729139105
Event date: 2025-08-27
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Point72 Asset Management, L.P.
Shares: 4,085,017.00 · Class: 6.7%
- Point72 Capital Advisors, Inc.
Shares: 4,085,017.00 · Class: 6.7%
- Steven A. Cohen
Shares: 4,085,017.00 · Class: 6.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-003977
- Form type
- SCHEDULE 13G
- Filer
- PLIANT THERAPEUTICS, INC.
- CIK
- CIK 1746473
- Filed
- Sep 04, 2025
- Reporting period
- Aug 27, 2025
- Description
- Schedule 13G beneficial ownership